1. Understanding Mass Tort Structure and Scope
Mass torts arise when a single product, environmental exposure, or event causes injury to numerous individuals, each of whom may pursue a separate claim but whose cases are often consolidated for pretrial management. The defining characteristic is the parallel causation question: did the defendant's conduct cause harm to each plaintiff, or does the injury stem from other sources? Courts manage these cases through multidistrict litigation (MDL) in federal court or coordinated state court proceedings, which streamline discovery and motion practice but also create pressure to settle large tranches of claims at once.
From a practitioner's perspective, the challenge is that individual defenses (comparative fault, lack of exposure, alternative causation) must be evaluated across a population rather than a single case. This means early investigation into the universe of potential claimants, their exposure histories, and the scientific or factual basis for causation becomes essential. Defendants often face discovery requests that seek production of thousands of documents and depositions of multiple corporate representatives, all while managing settlement discussions that may involve claims valuation models and bellwether trials.
The Role of Consolidation and Coordination
When multiple mass tort cases are filed in different federal courts, the Judicial Panel on Multidistrict Litigation (JPML) may consolidate them into a single MDL before one judge. This consolidation does not merge the underlying claims but centralizes pretrial discovery and motion practice. Defendants benefit from consistent rulings on evidentiary issues and discovery scope, but face the risk that unfavorable pretrial rulings affect all cases simultaneously. State courts also coordinate mass torts through joint assignment or administrative orders, though procedures vary by jurisdiction.
Causation As the Central Defense Issue
The core defense in mass tort litigation is typically causation: whether the defendant's product or conduct actually caused each plaintiff's injury. Unlike liability cases where breach of duty may be clear, mass torts often involve scientific or medical questions about dose-response relationships, latency periods, or competing risk factors. Defendants routinely retain expert witnesses to challenge the plaintiff's causation theory, and these expert battles often dominate pretrial proceedings and dispositive motion practice.
2. Strategic Considerations in Mass Tort Defense
Defense strategy in mass tort litigation balances individual case strength against aggregate settlement economics. A defendant facing 10,000 claims cannot litigate each one to judgment; instead, strategy focuses on identifying subgroups of claims with weaker causation evidence, negotiating global settlement frameworks, and managing trial risk through bellwether cases that test jury receptivity to defense theories.
| Strategic Element | Practical Application |
| Early Case Inventory | Assess the universe of claims by exposure type, injury category, and causation strength to identify defensible subgroups. |
| Expert Development | Retain epidemiologists, toxicologists, or other specialists early to challenge plaintiff causation theories and support Daubert motions. |
| Bellwether Selection | Work with plaintiffs' counsel and the court to select representative trial cases that reflect the range of claim strength and injury severity. |
| Settlement Architecture | Develop claims valuation models and settlement protocols that account for claim variations while controlling total exposure. |
Bellwether Trials and Their Impact
In many mass torts, the parties and court agree to try a small number of representative cases (often 4 to 12) before a jury, with the outcomes informing global settlement negotiations. These bellwether trials serve as market signals: a defense verdict or low plaintiff verdict may increase defendant leverage in settlement discussions, while a high plaintiff verdict may accelerate settlement pressure. Defendants must prepare bellwether cases with the same intensity as stand-alone trials because the verdict will influence settlement valuation for thousands of other claims.
3. Discovery and Procedural Challenges in Mass Tort Litigation
Mass tort discovery is exponentially more burdensome than single-case discovery. Defendants typically face requests for all documents related to product design, testing, marketing, adverse event reports, and regulatory communications. The sheer volume of discovery, often millions of pages, requires robust document management systems and careful privilege review to avoid inadvertent waiver. Additionally, defendants must produce representatives for depositions covering corporate knowledge, decision-making, and risk awareness across multiple time periods and business units.
In practice, these disputes rarely map neatly onto a single rule. Courts may impose page limits on document production, require parties to use search protocols or keyword filters, or order phased discovery to manage burden. A New York federal court managing a consolidated product liability MDL, for example, may require defendants to produce core documents first, then reserve supplemental production for later phases, which can delay resolution but prevents overwhelming the parties early on. The timing of discovery disputes and how thoroughly a defendant documents its decision-making process at the outset often determine whether courts will impose sanctions or limit later discovery scope.
Coordinating Across Multiple Venues
When mass tort claims remain in state courts rather than consolidate in federal MDL, defendants must coordinate defense strategy across multiple jurisdictions. Different states apply different causation standards, damage measures, and procedural rules, which can fragment the defense. Some defendants establish regional counsel and centralized strategy teams to ensure consistency while respecting local court rules and preferences.
4. The Role of Mass Torts in Broader Litigation Strategy
Understanding mass torts requires recognizing that they operate as a distinct category of complex litigation with unique procedural and economic pressures. Defendants should evaluate whether claims also implicate regulatory enforcement, criminal liability, or other parallel proceedings. For instance, environmental mass torts may involve EPA enforcement, and pharmaceutical cases may trigger FDA review or federal extortion defense considerations if settlement demands are viewed as coercive. Early assessment of the full litigation ecosystem helps defendants allocate resources and prioritize which forums present the greatest risk.
Forward-looking defense planning should focus on documenting the scientific and factual basis for contesting causation in the early stages of litigation, identifying and preserving key corporate witnesses and their knowledge, assessing whether the defendant's insurance policies provide adequate coverage for defense costs and settlements, and evaluating whether early settlement of clearly defensible claims may preserve resources for contested cases. Defendants should also prepare for the possibility that some mass tort litigation may settle through a class action framework or trust fund, which can offer finality but requires careful negotiation of release terms and claims procedures.
5. Key Issues to Review in a Mass Tort Lawsuit
A mass tort lawsuit often requires early analysis of causation evidence, expert testimony, exposure history, and the consistency of claims across multiple plaintiffs. Defendants should preserve relevant records, identify alternative causes of injury, and evaluate discovery obligations at an early stage. Careful review of these issues can help inform litigation strategy, settlement assessments, and procedural decision-making throughout the case.
04 May, 2026
